Trial Profile
Influence of severity of illness on the effects of eritoran and on other therapies for severe sepsis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Oct 2011
Price :
$35
*
At a glance
- Drugs Eritoran (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- 20 Oct 2011 New trial record